Zinc Completed Phase 2 Trials for Malignancies / Tumors, Solid

IndicationsStatusPurposePhase
CompletedNot Available2
clinicaltrials.gov IdentifierTitleDrugs
NCT01017731Study of Ramucirumab (IMC-1121B) Therapy and Corrected QT (QTc) Interval Changes